FDA 483 - Catalent Pharma Solutions LLC - September 28, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Catalent Pharma Solutions LLC in Morrisville, NC, a combination drug/device manufacturer, revealed significant deficiencies in design control procedures. The firm failed to adequately establish procedures and plans for design validation, verification, input, output, and overall design and development for its Albuterol Sulfate Inhalation Aerosol combination device. These findings indicate a lack of fundamental controls in the product development lifecycle.
ID · d907b32b-1a38-4df3-97fc-d0a2b5622a07